An Opportunity for Improving Osteoporosis Treatment in Home Health Care

Purpose: To examine osteoporosis prevention and treatment among home health care (HHC) patients at risk of fragility fracture in a large, Midwestern integrated HHC system. Methods: All patients who received HHC services in 2006 were identified. International Classification of Diseases, Ninth Revisio...

Full description

Bibliographic Details
Main Authors: Julie A. Switzer MD, Sharon J. Rolnick PhD, MPH, Jody M. Jackson RN, Nicole K. Schneider, Jeanne E. Dutkowski MS, C-ANP, Denise R. Edgett PHN
Format: Article
Language:English
Published: SAGE Publishing 2010-11-01
Series:Geriatric Orthopaedic Surgery & Rehabilitation
Online Access:https://doi.org/10.1177/2151458510386950
id doaj-02cedf012c234eabbaa05b759e161ddf
record_format Article
spelling doaj-02cedf012c234eabbaa05b759e161ddf2020-11-25T03:48:11ZengSAGE PublishingGeriatric Orthopaedic Surgery & Rehabilitation2151-45852151-45932010-11-01110.1177/2151458510386950An Opportunity for Improving Osteoporosis Treatment in Home Health CareJulie A. Switzer MD0Sharon J. Rolnick PhD, MPH1Jody M. Jackson RN2Nicole K. Schneider3Jeanne E. Dutkowski MS, C-ANP4Denise R. Edgett PHN5 University of Minnesota and Regions Hospital Orthopaedic Surgery Department, Saint Paul, MN, USA HealthPartners Research Foundation, Minneapolis, MN, USA HealthPartners Research Foundation, Minneapolis, MN, USA HealthPartners Research Foundation, Minneapolis, MN, USA University of Minnesota and Regions Hospital Orthopaedic Surgery Department, Saint Paul, MN, USA HealthPartners Research Foundation, Minneapolis, MN, USAPurpose: To examine osteoporosis prevention and treatment among home health care (HHC) patients at risk of fragility fracture in a large, Midwestern integrated HHC system. Methods: All patients who received HHC services in 2006 were identified. International Classification of Diseases, Ninth Revision ( ICD-9 ) diagnosis codes and pharmaceutical data were examined between January 1, 2004 and December 31, 2005 to determine risk status (high vs average) for fragility fracture. Patients with a documented diagnosis of osteoporosis, osteopenia, previous fragility fracture, stroke, or those taking a glucocorticoid were categorized as high risk. Pharmaceutical data (eg, estrogen, bisphosphonates) were obtained during the same 2-year period to determine treatment status. Descriptive statistics documented the proportion at high risk and treatment status. Inferential statistics tested differences in characteristics (age, gender, race, number of comorbidities) among high-risk patients with and without treatment. Results: 2798 patients were seen in HHC during 2006 and had utilization data available in 2004 and 2005. Of these, 754 were categorized as high risk and 2044 as average risk. Approximately one third (34%) of high-risk patients received osteoporosis medication compared to 4% of average risk ( P < .0001). We found no treatment differences based on age. Those with higher comorbidity profiles were less likely to receive treatment ( P < .0001). Conclusion: Only 34% of HHC patients at high risk for fracture received adequate treatment. Patients with more comorbidities were least likely to receive treatment. Since these individuals are receiving medical and nursing care, an opportunity exists to increase treatment rates for those at greatest risk.https://doi.org/10.1177/2151458510386950
collection DOAJ
language English
format Article
sources DOAJ
author Julie A. Switzer MD
Sharon J. Rolnick PhD, MPH
Jody M. Jackson RN
Nicole K. Schneider
Jeanne E. Dutkowski MS, C-ANP
Denise R. Edgett PHN
spellingShingle Julie A. Switzer MD
Sharon J. Rolnick PhD, MPH
Jody M. Jackson RN
Nicole K. Schneider
Jeanne E. Dutkowski MS, C-ANP
Denise R. Edgett PHN
An Opportunity for Improving Osteoporosis Treatment in Home Health Care
Geriatric Orthopaedic Surgery & Rehabilitation
author_facet Julie A. Switzer MD
Sharon J. Rolnick PhD, MPH
Jody M. Jackson RN
Nicole K. Schneider
Jeanne E. Dutkowski MS, C-ANP
Denise R. Edgett PHN
author_sort Julie A. Switzer MD
title An Opportunity for Improving Osteoporosis Treatment in Home Health Care
title_short An Opportunity for Improving Osteoporosis Treatment in Home Health Care
title_full An Opportunity for Improving Osteoporosis Treatment in Home Health Care
title_fullStr An Opportunity for Improving Osteoporosis Treatment in Home Health Care
title_full_unstemmed An Opportunity for Improving Osteoporosis Treatment in Home Health Care
title_sort opportunity for improving osteoporosis treatment in home health care
publisher SAGE Publishing
series Geriatric Orthopaedic Surgery & Rehabilitation
issn 2151-4585
2151-4593
publishDate 2010-11-01
description Purpose: To examine osteoporosis prevention and treatment among home health care (HHC) patients at risk of fragility fracture in a large, Midwestern integrated HHC system. Methods: All patients who received HHC services in 2006 were identified. International Classification of Diseases, Ninth Revision ( ICD-9 ) diagnosis codes and pharmaceutical data were examined between January 1, 2004 and December 31, 2005 to determine risk status (high vs average) for fragility fracture. Patients with a documented diagnosis of osteoporosis, osteopenia, previous fragility fracture, stroke, or those taking a glucocorticoid were categorized as high risk. Pharmaceutical data (eg, estrogen, bisphosphonates) were obtained during the same 2-year period to determine treatment status. Descriptive statistics documented the proportion at high risk and treatment status. Inferential statistics tested differences in characteristics (age, gender, race, number of comorbidities) among high-risk patients with and without treatment. Results: 2798 patients were seen in HHC during 2006 and had utilization data available in 2004 and 2005. Of these, 754 were categorized as high risk and 2044 as average risk. Approximately one third (34%) of high-risk patients received osteoporosis medication compared to 4% of average risk ( P < .0001). We found no treatment differences based on age. Those with higher comorbidity profiles were less likely to receive treatment ( P < .0001). Conclusion: Only 34% of HHC patients at high risk for fracture received adequate treatment. Patients with more comorbidities were least likely to receive treatment. Since these individuals are receiving medical and nursing care, an opportunity exists to increase treatment rates for those at greatest risk.
url https://doi.org/10.1177/2151458510386950
work_keys_str_mv AT julieaswitzermd anopportunityforimprovingosteoporosistreatmentinhomehealthcare
AT sharonjrolnickphdmph anopportunityforimprovingosteoporosistreatmentinhomehealthcare
AT jodymjacksonrn anopportunityforimprovingosteoporosistreatmentinhomehealthcare
AT nicolekschneider anopportunityforimprovingosteoporosistreatmentinhomehealthcare
AT jeanneedutkowskimscanp anopportunityforimprovingosteoporosistreatmentinhomehealthcare
AT deniseredgettphn anopportunityforimprovingosteoporosistreatmentinhomehealthcare
AT julieaswitzermd opportunityforimprovingosteoporosistreatmentinhomehealthcare
AT sharonjrolnickphdmph opportunityforimprovingosteoporosistreatmentinhomehealthcare
AT jodymjacksonrn opportunityforimprovingosteoporosistreatmentinhomehealthcare
AT nicolekschneider opportunityforimprovingosteoporosistreatmentinhomehealthcare
AT jeanneedutkowskimscanp opportunityforimprovingosteoporosistreatmentinhomehealthcare
AT deniseredgettphn opportunityforimprovingosteoporosistreatmentinhomehealthcare
_version_ 1724499739005681664